Search filters

List of works by Olivier Nibourel

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

scientific article published on 07 February 2019

Absence of CALR mutations in JAK2-negative polycythemia.

scientific article published on 6 October 2016

Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy

scientific article published on 09 August 2011

Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript.

scientific article

Acute myeloid leukemia with translocation t(3;5): new molecular insights.

scientific article published on 12 February 2013

C/EBPA methylation is common in T-ALL but not in M0 AML.

scientific article published in February 2009

C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations

scientific article

Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scale

scientific article

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial

scientific article

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.

scientific article published on 22 February 2018

Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: a study of the French Hauts-de-France AML observatory

article

Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

scientific article published on 21 February 2008

Copy-number analysis identified new prognostic marker in acute myeloid leukemia

scientific article

Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

scientific article published on 01 March 2011

Disease escape with the selective loss of the Philadelphia chromosome after tyrosine kinase inhibitor exposure in Ph-positive acute lymphoblastic leukemia

scientific article published on 27 January 2020

Familial myeloid malignancies with germline TET2 mutation

scientific article published on 11 December 2019

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.

scientific article

Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

scientific article published on 21 October 2015

Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients

scientific article published on 03 August 2010

High-throughput genomic analysis in Waldenström's macroglobulinemia

scientific article published on February 2011

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association

scientific article published on 13 October 2015

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

scientific article published on 09 January 2017

Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia.

scientific article published on 31 December 2014

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

scientific article published on 20 May 2010

Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia

scientific article published on 01 December 2019

MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin

scientific article

MYD88 L265P mutation in Waldenstrom macroglobulinemia.

scientific article published on 26 March 2013

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia.

scientific article published on 31 May 2016

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.

scientific article published on 29 November 2011

Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA

scientific article published on 08 March 2014

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

scientific article published on 19 November 2015

Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia

scientific article published on 03 June 2011

Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions

scientific article published on 16 February 2011

Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia

scientific article

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.

scientific article

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

scientific article

Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group

scientific article published on 9 October 2015

Quantification of JAK2V617F mutation by next-generation sequencing technology.

scientific article published on 13 May 2013

Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML

scientific article published on 13 September 2007

TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.

scientific article published on 16 January 2017

TP53 mutation and its prognostic significance in Waldenstrom's Macroglobulinemia

scientific article

Waved aCGH: to smooth or not to smooth.

scientific article

Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association

scientific article

Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia

scientific article published on 15 July 2011

Paulina is supported by:

About Paulina

Help